Posted On: 11/18/2014 9:32:00 PM
Post# of 273349
Aeterna Zentaris (AEZS) 0.55 $AEZS
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Aeterna Zentaris, Inc. to Contact Brower Piven Before the January 12, 2015 Lead Plaintiff Deadline in Class Action Lawsuit -- AEZS
GlobeNewswire - Tue Nov 18, 1:35PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Aeterna Zentaris, Inc. ("Aeterna Zentaris" or the "Company"
(Nasdaq:AEZS) securities during the period between October 18, 2012 and November 6, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until January 12, 2015 to seek appointment as lead plaintiff.
AEZS: 0.55 (unch)
Notice of Filing of Securities Fraud Class Action against Aeterna Zentaris Inc. by Abraham, Fruchter & Twersky, LLP
Business Wire - Mon Nov 17, 9:33AM CST
Abraham, Fruchter & Twersky, LLP has filed a securities fraud class action against Aeterna Zentaris Inc. ("Aeterna Zentaris" or the "Company" (NASDAQ:AEZS) and certain of its senior executives in the United States District Court for the District of New Jersey (the "Court" .
AEZS: 0.55 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aeterna Zentaris, Inc. - AEZS
PR Newswire - Fri Nov 14, 12:46PM CST
Pomerantz LLP is investigating claims on behalf of investors of Aeterna Zentaris, Inc. ("Aeterna" or the "Company" (NASDAQ: AEZS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.
AEZS: 0.55 (unch)
EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against Aeterna Zentaris, Inc. -- AEZS
GlobeNewswire - Tue Nov 11, 8:23PM CST
The Rosen Law Firm announces that it has filed a class action lawsuit on behalf of purchasers of Aeterna Zentaris, Inc. (Nasdaq:AEZS) securities between October 18, 2012 and November 6, 2014. The lawsuit seeks to recover damages for Aeterna Zentaris investors under the federal securities laws.
AEZS: 0.55 (unch)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aeterna Zentaris Inc. (AEZS) To Contact The Firm
PR Newswire - Tue Nov 11, 4:15PM CST
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Aeterna Zentaris Inc. ("Aeterna" or the "Company" (NASDAQ: AEZS).
AEZS: 0.55 (unch)
INVESTOR ALERT: Investigation of Aeterna Zentaris, Inc. Announced by Glancy Binkow & Goldberg LLP
Business Wire - Mon Nov 10, 9:32AM CST
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Aeterna Zentaris, Inc. ("Aeterna Zentaris" or the "Company" (NASDAQ:AEZS) concerning possible violations of federal securities laws. The investigation is focused on the Company's operations and financial prospects.
AEZS: 0.55 (unch)
Why I Still Remain Bearish On AEterna Zentaris
Daniel Ward - at Seeking Alpha - Sat Nov 08, 7:21AM CST
AEZS: 0.55 (unch)
SHAREHOLDER ALERT: Investigation on Behalf of Aeterna Zentaris, Inc. Investors Announced by Law Offices of Howard G. Smith
Business Wire - Fri Nov 07, 4:08PM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Aeterna Zentaris, Inc. ("Aeterna Zentaris" or the "Company" (NASDAQ:AEZS). The investigation concerns possible violations of federal securities laws and focuses on certain statements issued by Aeterna Zentaris concerning the Company's operations and business prospects.
AEZS: 0.55 (unch)
Downgrade Alert for AEterna Zentaris (AEZS)
Comtex SmarTrend(R) - Fri Nov 07, 6:53AM CST
AEterna Zentaris (NASDAQ:AEZS) was downgraded from Buy to Neutral at H.C. Wainwright today. The stock closed yesterday at $0.65 on volume of 22.8 million shares, above average daily volume of 1.6 million. In the past 52 weeks, shares of AEterna Zentaris have traded between a low of $0.57 and a high of $1.74 and closed yesterday at $0.65, which is 14% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 1.6% while the 200-day MA has slid 0.5%.
AEZS: 0.55 (unch)
The Rosen Law Firm Announces Investigation of Securities Claims Against Aeterna Zentaris, Inc.
Business Wire - Thu Nov 06, 6:02PM CST
The Rosen Law Firm announces that it is investigating potential securities fraud claims against Aeterna Zentaris, Inc. (NASDAQ:AEZS) resulting from its announcement that the FDA would not approve its New Drug Application ("NDA" .
AEZS: 0.55 (unch)
Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 11:47AM CST
SWIR: 39.32 (+0.67), PERI: 5.62 (-0.15), RMGN: 1.32 (+0.10), WWWW: 16.77 (+0.21), ASTI: 1.82 (+0.07), GNW: 9.36 (+0.03), SNMX: 5.34 (+0.18), ALXA: 1.50 (+0.02), PLUS: 68.44 (+0.09), PPO: 52.49 (-0.03), NSM: 27.82 (-0.50), AEZS: 0.55 (unch), WAC: 16.80 (+0.27), KATE: 28.99 (+0.26), CGG: 8.60 (+0.08), ANDE: 54.48 (+0.28), ENG: 1.93 (+0.03), PLNR: 7.39 (+0.34), ALG: 45.51 (+0.56), SZYM: 3.21 (-0.23)
Aeterna Zentaris slammed after FDA rejection
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 10:42AM CST
AEZS: 0.55 (unch)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:14AM CST
ACAS: 14.87 (-0.12), WWWW: 16.77 (+0.21), PHMD: 2.21 (-0.08), RVLT: 1.53 (unch), SNMX: 5.34 (+0.18), PBR: 9.42 (+0.09), QCOM: 72.01 (+1.61), GNRC: 43.83 (+1.95), HZNP: 12.85 (+0.35), PESI: 4.39 (unch), WAC: 16.80 (+0.27), TRUE: 17.42 (-0.18), KATE: 28.99 (+0.26), DRYS: 1.43 (+0.02), Z: 118.96 (+1.10), WFM: 47.89 (+0.48), SWIR: 39.32 (+0.67), COT: 6.69 (-0.19), CSOD: 30.57 (+0.36), MCP: 1.20 (-0.06), GNW: 9.36 (+0.03), CECO: 5.54 (-0.05), GERN: 3.17 (+0.19), NDLS: 22.65 (-0.22), MEET: 1.80 (-0.01), AEZS: 0.55 (unch), DATA: 82.10 (-1.21), PLNR: 7.39 (+0.34), SZYM: 3.21 (-0.23)
FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone Deficiency
PR Newswire - Thu Nov 06, 6:00AM CST
Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company" today announced that the Company has received a Complete Response Letter ("CRL" from the U.S. Food and Drug Administration ("FDA" for its New Drug Application ("NDA" for MacrilenTM (macimorelin), a novel orally-active ghrelin agonist, for use in evaluating adult growth hormone deficiency ("AGHD" . Based on its review, the FDA has determined that the NDA cannot be approved in its present form.
AEZ.TO: 0.63 (-0.01), AEZS: 0.55 (unch)
Update: AEterna Zentaris Q3 2014 Earnings
Samreen Agha - at Seeking Alpha - Thu Nov 06, 3:58AM CST
AEZS: 0.55 (unch)
Aeterna Zentaris' (AEZS) CEO David Dodd on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 5:30PM CST
AEZS: 0.55 (unch)
IIROC Trading Halt - AEX
CNW Group - Wed Nov 05, 2:52PM CST
The following issues have been halted by IIROC:
AEX.VN: 0.110 (unch), AEZS: 0.55 (unch)
PDUFA date today for Aeterna's macimorelin acetate
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 11:02AM CST
AEZS: 0.55 (unch)
AEterna Zentaris Up 11.7%, Shares Break Through Resistance (AEZS)
Comtex SmarTrend(R) - Wed Nov 05, 10:06AM CST
AEterna Zentaris (NASDAQ:AEZS) is one of today's best performing low-priced stocks, up 11.7% to $1.24 on 3.1x average daily volume. Thus far today, AEterna Zentaris has traded 4.3 million shares, vs. average volume of 1.4 million shares per day. The stock has outperformed the Dow (11.7% to the Dow's 0.4%) and outperformed the S&P 500 (11.7% to the S&P's 0.4%) during today's trading.
AEZS: 0.55 (unch)
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Aeterna Zentaris, Inc. to Contact Brower Piven Before the January 12, 2015 Lead Plaintiff Deadline in Class Action Lawsuit -- AEZS
GlobeNewswire - Tue Nov 18, 1:35PM CST
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Aeterna Zentaris, Inc. ("Aeterna Zentaris" or the "Company"
(Nasdaq:AEZS) securities during the period between October 18, 2012 and November 6, 2014, inclusive (the "Class Period" . Investors who wish to become proactively involved in the litigation have until January 12, 2015 to seek appointment as lead plaintiff. AEZS: 0.55 (unch)
Notice of Filing of Securities Fraud Class Action against Aeterna Zentaris Inc. by Abraham, Fruchter & Twersky, LLP
Business Wire - Mon Nov 17, 9:33AM CST
Abraham, Fruchter & Twersky, LLP has filed a securities fraud class action against Aeterna Zentaris Inc. ("Aeterna Zentaris" or the "Company"
(NASDAQ:AEZS) and certain of its senior executives in the United States District Court for the District of New Jersey (the "Court" . AEZS: 0.55 (unch)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Aeterna Zentaris, Inc. - AEZS
PR Newswire - Fri Nov 14, 12:46PM CST
Pomerantz LLP is investigating claims on behalf of investors of Aeterna Zentaris, Inc. ("Aeterna" or the "Company"
(NASDAQ: AEZS). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237. AEZS: 0.55 (unch)
EQUITY ALERT: The Rosen Law Firm Files Securities Fraud Class Action Against Aeterna Zentaris, Inc. -- AEZS
GlobeNewswire - Tue Nov 11, 8:23PM CST
The Rosen Law Firm announces that it has filed a class action lawsuit on behalf of purchasers of Aeterna Zentaris, Inc. (Nasdaq:AEZS) securities between October 18, 2012 and November 6, 2014. The lawsuit seeks to recover damages for Aeterna Zentaris investors under the federal securities laws.
AEZS: 0.55 (unch)
INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Aeterna Zentaris Inc. (AEZS) To Contact The Firm
PR Newswire - Tue Nov 11, 4:15PM CST
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at Aeterna Zentaris Inc. ("Aeterna" or the "Company"
(NASDAQ: AEZS). AEZS: 0.55 (unch)
INVESTOR ALERT: Investigation of Aeterna Zentaris, Inc. Announced by Glancy Binkow & Goldberg LLP
Business Wire - Mon Nov 10, 9:32AM CST
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of investors of Aeterna Zentaris, Inc. ("Aeterna Zentaris" or the "Company"
(NASDAQ:AEZS) concerning possible violations of federal securities laws. The investigation is focused on the Company's operations and financial prospects. AEZS: 0.55 (unch)
Why I Still Remain Bearish On AEterna Zentaris
Daniel Ward - at Seeking Alpha - Sat Nov 08, 7:21AM CST
AEZS: 0.55 (unch)
SHAREHOLDER ALERT: Investigation on Behalf of Aeterna Zentaris, Inc. Investors Announced by Law Offices of Howard G. Smith
Business Wire - Fri Nov 07, 4:08PM CST
Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of investors of Aeterna Zentaris, Inc. ("Aeterna Zentaris" or the "Company"
(NASDAQ:AEZS). The investigation concerns possible violations of federal securities laws and focuses on certain statements issued by Aeterna Zentaris concerning the Company's operations and business prospects. AEZS: 0.55 (unch)
Downgrade Alert for AEterna Zentaris (AEZS)
Comtex SmarTrend(R) - Fri Nov 07, 6:53AM CST
AEterna Zentaris (NASDAQ:AEZS) was downgraded from Buy to Neutral at H.C. Wainwright today. The stock closed yesterday at $0.65 on volume of 22.8 million shares, above average daily volume of 1.6 million. In the past 52 weeks, shares of AEterna Zentaris have traded between a low of $0.57 and a high of $1.74 and closed yesterday at $0.65, which is 14% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 1.6% while the 200-day MA has slid 0.5%.
AEZS: 0.55 (unch)
The Rosen Law Firm Announces Investigation of Securities Claims Against Aeterna Zentaris, Inc.
Business Wire - Thu Nov 06, 6:02PM CST
The Rosen Law Firm announces that it is investigating potential securities fraud claims against Aeterna Zentaris, Inc. (NASDAQ:AEZS) resulting from its announcement that the FDA would not approve its New Drug Application ("NDA"
. AEZS: 0.55 (unch)
Midday Gainers/Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 11:47AM CST
SWIR: 39.32 (+0.67), PERI: 5.62 (-0.15), RMGN: 1.32 (+0.10), WWWW: 16.77 (+0.21), ASTI: 1.82 (+0.07), GNW: 9.36 (+0.03), SNMX: 5.34 (+0.18), ALXA: 1.50 (+0.02), PLUS: 68.44 (+0.09), PPO: 52.49 (-0.03), NSM: 27.82 (-0.50), AEZS: 0.55 (unch), WAC: 16.80 (+0.27), KATE: 28.99 (+0.26), CGG: 8.60 (+0.08), ANDE: 54.48 (+0.28), ENG: 1.93 (+0.03), PLNR: 7.39 (+0.34), ALG: 45.51 (+0.56), SZYM: 3.21 (-0.23)
Aeterna Zentaris slammed after FDA rejection
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 10:42AM CST
AEZS: 0.55 (unch)
Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:14AM CST
ACAS: 14.87 (-0.12), WWWW: 16.77 (+0.21), PHMD: 2.21 (-0.08), RVLT: 1.53 (unch), SNMX: 5.34 (+0.18), PBR: 9.42 (+0.09), QCOM: 72.01 (+1.61), GNRC: 43.83 (+1.95), HZNP: 12.85 (+0.35), PESI: 4.39 (unch), WAC: 16.80 (+0.27), TRUE: 17.42 (-0.18), KATE: 28.99 (+0.26), DRYS: 1.43 (+0.02), Z: 118.96 (+1.10), WFM: 47.89 (+0.48), SWIR: 39.32 (+0.67), COT: 6.69 (-0.19), CSOD: 30.57 (+0.36), MCP: 1.20 (-0.06), GNW: 9.36 (+0.03), CECO: 5.54 (-0.05), GERN: 3.17 (+0.19), NDLS: 22.65 (-0.22), MEET: 1.80 (-0.01), AEZS: 0.55 (unch), DATA: 82.10 (-1.21), PLNR: 7.39 (+0.34), SZYM: 3.21 (-0.23)
FDA Issues Complete Response Letter for Aeterna Zentaris' Macrilen™ NDA in Adult Growth Hormone Deficiency
PR Newswire - Thu Nov 06, 6:00AM CST
Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company"
today announced that the Company has received a Complete Response Letter ("CRL" from the U.S. Food and Drug Administration ("FDA" for its New Drug Application ("NDA" for MacrilenTM (macimorelin), a novel orally-active ghrelin agonist, for use in evaluating adult growth hormone deficiency ("AGHD" . Based on its review, the FDA has determined that the NDA cannot be approved in its present form. AEZ.TO: 0.63 (-0.01), AEZS: 0.55 (unch)
Update: AEterna Zentaris Q3 2014 Earnings
Samreen Agha - at Seeking Alpha - Thu Nov 06, 3:58AM CST
AEZS: 0.55 (unch)
Aeterna Zentaris' (AEZS) CEO David Dodd on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Wed Nov 05, 5:30PM CST
AEZS: 0.55 (unch)
IIROC Trading Halt - AEX
CNW Group - Wed Nov 05, 2:52PM CST
The following issues have been halted by IIROC:
AEX.VN: 0.110 (unch), AEZS: 0.55 (unch)
PDUFA date today for Aeterna's macimorelin acetate
Seeking Alpha - at Seeking Alpha - Wed Nov 05, 11:02AM CST
AEZS: 0.55 (unch)
AEterna Zentaris Up 11.7%, Shares Break Through Resistance (AEZS)
Comtex SmarTrend(R) - Wed Nov 05, 10:06AM CST
AEterna Zentaris (NASDAQ:AEZS) is one of today's best performing low-priced stocks, up 11.7% to $1.24 on 3.1x average daily volume. Thus far today, AEterna Zentaris has traded 4.3 million shares, vs. average volume of 1.4 million shares per day. The stock has outperformed the Dow (11.7% to the Dow's 0.4%) and outperformed the S&P 500 (11.7% to the S&P's 0.4%) during today's trading.
AEZS: 0.55 (unch)
(0)
(0)
